Skip to main content

Re-evaluating Opioid Use in Chronic Pain: Then and Now

Opioid drugs have been on the marketplace for decades. But it wasn't until the 1980s that the idea of using long acting opioid products for chronic pain became reality.Before that time, opiates were mostly used short term; long term use of these products was pretty much limited to terminal illnesses, including cancer.  At that time, I was a newly licensed pharmacist; we were taught that, if someone had a terminal illness, quality of life was more important. If a terminally ill person became addicted to pain medication, so be it.




Dr. Russell Portenoy was one of the early proponents using opioid medications for patients with chronic pain conditions.  In the late 1980s, he co-authored a paper about a study using these products in this way.  The study was based on a relatively small sample: only 38 patients were involved. The authors contended that the benefits of long term opiate therapy experienced by the study subjects could be of potential benefit to many people with chronic pain. In the 1990s he and his follower asserted that less than 1% of users would become addicted; overdoses would not be a common problem; and that it would be easy to discontinue usage if/when that was necessary.



Dr Portenoy's theory took hold, and the opioid use for chronic pain skyrocketed.  The predictions of Dr. Portenoy and his associates have not come true.  Here are some scary facts about the real picture:


  • More than 16,000 people die from opioid overdoses every year.
  • Before the year 2000, less than 1 person per 10,000 was admitted to an opioid addiction treatment program.  By the year 2010, 5.4 persons per 10,000 fell victim to that fate.
  • Before the year 2000, approximately 2 kilograms of opioids were sold per 10,000 persons. By the year 2010, that number more than tripled to 7.1 kilograms per 10,000 persons.
So where are we now?

Dr. Portenoy and other pain doctors, who so widely promoted this concept in the mid 80's now admit that they erred in that they overstated the benefits of these drugs without paying much attention to the risks.  In an interview with the Wall Street Journal (Dec 2012), Dr. Portenoy says, " We didn't know then what we know now."

You can say I'm old school...but maybe what I learned back in pharmacy school about opioids was right all along.

Sources: Wall Street Journal; Wikimedia







Comments

Popular posts from this blog

Living with Chronic pain hits the big screen!

Been to the movies lately?  Jennifer Aniston is on the big screen in a recent release titled "Cake." Her character, Claire is a victim of chronic pain...she belongs to a support group, where all of the members are coming to terms with the suicide of one of their members.  Of course, she also takes pain medication and addiction is another of her problems...and of course there's more! I guess I am writing this post just to bring readers' attention to the fact that Hollywood has become aware of the crisis that is chronic pain.  This movie is a testament to that. People that don't have to live with this kind of pain don't fully understand the whole story.  Maybe this movie will shed some light on the issues. Here is the official trailer for the movie: Sources: prweb;NorthJersey.com;YouTube

Effectiveness Of Ozone Injections Is No Longer Up In The Air

Most of us know someone who has osteoarthritis, if we don't have it ourselves.  Joint replacement surgery is a pretty common remedy when the joint becomes severely damaged and the patient is in a lot of pain.  With risk of complications from such a surgery, perhaps an alternative treatment should be tried first. One such remedy is the injection of a synthetic version of collagen(e.g. Synvisc®) into the affected joint.  This procedure restores the cushioning to a joint that has degenerated over the years. It can diminish the pain substantially and help put off joint replacement surgery for months to years.  The biggest drawback is that these products are expensive.   GoodRX , a web site that can be used to estimate the cost of medications, estimates the cost of these products to be over $1,000 each. Here's another example--and I am not sure how widely accepted this protocol has become since study authors introduced it in November 2015.  Are you r...

Fibromyalgia Week: Day 2

Tender points...click caption for WebMD animation Tender points are a unique feature of fibromaylgia.  There are 18 such points on the human body (9 pairs as shown).  Using special technique by hand or a dolorimeter, a fibromyalgia patient will experience pain in at least 11 points, and there will be at least one painful tender point in each quadrant of the body! One study found that up to 96% of fibromyalgia patients suffer from sleep disorders. It is believed that this is responsible for a deprivation of delta sleep, during which human growth hormone is produced. This hormone is essential to tissue repair. Other common problems in fibromyalgia are fatigue, concentration/memory ("fibro fog"), and depression.  There is no doubt in my mind that just enabling the patient to sleep well on a regular basis would be of great benefit! It is not uncommon for fibromyalgia patients to have coexisting conditions--some of these are lupus, disease, irritable bowel syndrom...